MedMen Announces Delay of Filing of Financial Statements for the Year Ended July 1, 2023 and Issuance of Management Cease Trade OrderPosted by On

[ad_1]

LOS ANGELES–(BUSINESS WIRE)–MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis company with operations across the United States, today announced it expects to be late in filing its financial statements and management’s discussion and analysis for the year ended July 1, 2023 (the “2023 Financial Filings”) under applicable Canadian securities laws. The Company is unable to timely file, without unreasonable effort and expense, its Annual Report on

[ad_2]

Source link

Business

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.